Reporter
-
September 21, 2012
VU, Bristol-Myers to collaborate on Parkinson’s therapies
Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease. -
September 21, 2012
HER2 may impact lung cancer therapy
A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies. -
September 20, 2012
Wellons named chief of Pediatric Neurosurgery
The Department of Neurological Surgery has recruited John “Jay” Wellons III, M.D., MSPH, to serve as chief of Pediatric Neurosurgery. -
September 20, 2012
Mchaourab to lead Chemical and Physical Biology program
Hassane Mchaourab, Ph.D., professor of Molecular Physiology & Biophysics, Physics and Chemistry, has been named the new director of the Ph.D.-granting Chemical and Physical Biology (CPB) program at Vanderbilt University. -
September 20, 2012
Cancer Wellness Program launches ‘Thrivership’ classes
Adult cancer patients and survivors are invited to participate in Vanderbilt-Ingram Cancer Center’s new Thrivership Program, which is designed to restore wellness through physical activity, enhanced nutrition, body awareness and emotional well-being. -
September 20, 2012
Schaffner lauded for epidemiology contributions
William Schaffner, M.D., professor and chair of Preventive Medicine, is the 2012 recipient of the American College of Epidemiology’s Abraham Lilienfeld Award, in recognition of his contributions and leadership in the discipline of epidemiology. -
September 20, 2012
Discovery Lecture set to focus on mechanisms of fear
Psychiatrist and fear researcher Kerry Ressler, M.D., Ph.D., will deliver the next Flexner Discovery Lecture on Thursday, Sept. 27.